Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Efficacy and Safety of an Inactivated Virus-Particle Vaccine for Sars-Cov-2, Biv1-Coviran: Randomised, Placebo Controlled, Double Blind, Multicentre, Phase 3 Clinical Trial
Shahrzad Ahangarzadeh
Shahrzad Ahangarzadeh

Assistant Professor of Medical Biotechnology

Infectious Diseases and Tropical Medicine Research Center

Isfahan University of Medical Sciences

Related Documents
1. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
All Documents
1. Impact of Selenium Nanoparticle-Enriched Lactobacilli Feeding Against Escherichia Coli O157:H7 Infection of Balb/C Mice, Probiotics and Antimicrobial Proteins (2024)
2. A Process Evaluation of the Isfahan Antibiotic Awareness Campaign: Developing Engagement on Antimicrobial Resistance, Advanced Biomedical Research (2023)
3. Bioinformatic Screening of Compounds From Iranian Lamiaceae Family Members Against Sars-Cov-2 Spike Protein, Letters in Drug Design and Discovery (2023)
4. Comparative Analysis and Identification of Spike Mutations in Iranian Covid-19 Samples From the First Three Waves of Disease, Advanced Biomedical Research (2023)
5. Evaluation of Specific Igg Antibody in Subjects Who Had Been Previously Infected With Sars-Cov-2, Advanced Biomedical Research (2023)
6. In-Silico Design of a New Multi-Epitope Vaccine Candidate Against Sars-Cov-2, Acta Virologica (2023)
7. Molecular and Antigen Detection, Phylogenetics, and Immunoinformatics Study of the Zoonotic Coronavirus in Iranian Diarrheic Calves, Advanced Biomedical Research (2023)
8. Probiotic Potential, Antiproliferative, and Proapoptotic Activities of Lactobacillus Fermentum Isolated From Breast Milk, Advanced Biomedical Research (2023)
9. The Effect of Mutation on Neurotoxicity Reduction of New Chimeric Reteplase, a Computational Study, Research in Pharmaceutical Sciences (2023)
10. Association of Clinical Features With Spike Glycoprotein Mutations in Iranian Covid-19 Patients, Journal of Clinical Medicine (2022)
11. Gene Editing-Based Technologies for Beta-Hemoglobinopathies Treatment, Biology (2022)
12. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)
13. Acetate Kinase a Antisense Delivery by Pamam Dendrimer for Decreasing Acetate Production and Increasing the Production of Recombinant Albumin in E. Coli, Iranian Journal of Biotechnology (2021)
14. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
15. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
16. Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599)), Biomedicine and Pharmacotherapy (2021)
17. Corrigendum To: “Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384x), (10.1016/J.Biopha.2021.111599)), Biomedicine and Pharmacotherapy (2021)
18. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
19. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
20. Recent Developments in Antibody Derivatives Against Colorectal Cancer; a Review, Life Sciences (2021)
21. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
22. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
23. Virtual Screening for the Identification of Potential Candidate Molecules Against Envelope (E) and Membrane (M) Proteins of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
24. An Update on Antiviral Antibody-Based Biopharmaceuticals, International Immunopharmacology (2020)
25. An Update on Antiviral Antibody-Based Biopharmaceuticals, International Immunopharmacology (2020)
26. Bioinformatics Prediction and Experimental Validation of Vh Antibody Fragment Interacting With Neisseria Meningitidis Factor H Binding Protein, Iranian Journal of Basic Medical Sciences (2020)
27. Bioinformatics Prediction and Experimental Validation of Vh Antibody Fragment Interacting With Neisseria Meningitidis Factor H Binding Protein, Iranian Journal of Basic Medical Sciences (2020)
28. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
29. Development of Polyepitopic Immunogenic Contrast Against Hepatitis C Virus 1A-6A Genotype by in Silico Approach, Biomedical and Biotechnology Research Journal (2020)
30. Antibody-Drug Therapeutic Conjugates: Potential of Antibody-Sirnas in Cancer Therapy, Journal of Cellular Physiology (2019)
31. Antibody-Drug Therapeutic Conjugates: Potential of Antibody-Sirnas in Cancer Therapy, Journal of Cellular Physiology (2019)
32. Bicyclic Peptides: Types, Synthesis and Applications, Drug Discovery Today (2019)
33. Bicyclic Peptides: Types, Synthesis and Applications, Drug Discovery Today (2019)
34. Bioinformatics Evaluation of Novel Ribosome Display-Selected Single Chain Variable Fragment (Scfv) Structure With Factor H Binding Protein Through Docking, Journal of Theoretical and Computational Chemistry (2017)
35. In Silico Evaluation of the Interactions Among Two Selected Single Chain Variable Fragments (Scfvs) and Esat-6 Antigen of Mycobacterium Tuberculosis, Journal of Theoretical and Computational Chemistry (2017)
36. Selection of Single-Chain Variable Fragments Specific for Mycobacterium Tuberculosis Esat-6 Antigen Using Ribosome Display, Iranian Journal of Basic Medical Sciences (2017)
37. Targeted Cancer Therapy Through Antibody Fragments-Decorated Nanomedicines, Journal of Controlled Release (2017)